Page last updated: 2024-09-05

technetium tc 99m pentetate and Acquired Nephrogenic Diabetes Insipidus

technetium tc 99m pentetate has been researched along with Acquired Nephrogenic Diabetes Insipidus in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imamine, H; Kobayashi, M; Mizuno, H; Ohro, Y; Sasaki, S; Sugiyama, Y; Togari, H; Uchida, S1

Other Studies

1 other study(ies) available for technetium tc 99m pentetate and Acquired Nephrogenic Diabetes Insipidus

ArticleYear
Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus.
    Endocrine, 2004, Volume: 24, Issue:1

    Topics: Adolescent; Adult; Age of Onset; Antihypertensive Agents; Child; Child, Preschool; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Diuretics; Glomerular Filtration Rate; Hemostatics; Humans; Male; Osmolar Concentration; Radiopharmaceuticals; Receptors, Vasopressin; Renal Agents; Saline Solution, Hypertonic; Sodium Chloride Symporter Inhibitors; Technetium Tc 99m Pentetate; Trichlormethiazide

2004